Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 16:12:845334.
doi: 10.3389/fonc.2022.845334. eCollection 2022.

Elaboration and Validation of a Nomogram Based on Axillary Ultrasound and Tumor Clinicopathological Features to Predict Axillary Lymph Node Metastasis in Patients With Breast Cancer

Affiliations

Elaboration and Validation of a Nomogram Based on Axillary Ultrasound and Tumor Clinicopathological Features to Predict Axillary Lymph Node Metastasis in Patients With Breast Cancer

Yubo Liu et al. Front Oncol. .

Abstract

Background: This study aimed at constructing a nomogram to predict axillary lymph node metastasis (ALNM) based on axillary ultrasound and tumor clinicopathological features.

Methods: A retrospective analysis of 281 patients with pathologically confirmed breast cancer was performed between January 2015 and March 2018. All patients were randomly divided into a training cohort (n = 197) and a validation cohort (n = 84). Univariate and multivariable logistic regression analyses were performed to identify the clinically important predictors of ALNM when developin1 g the nomogram. The area under the curve (AUC), calibration plots, and decision curve analysis (DCA) were used to assess the discrimination, calibration, and clinical utility of the nomogram.

Results: In univariate and multivariate analyses, lymphovascular invasion (LVI), axillary lymph node (ALN) cortex thickness, and an obliterated ALN fatty hilum were identified as independent predictors and integrated to develop a nomogram for predicting ALNM. The nomogram showed favorable sensitivity for ALNM with AUCs of 0.87 (95% confidence interval (CI), 0.81-0.92) and 0.84 (95% CI, 0.73-0.92) in the training and validation cohorts, respectively. The calibration plots of the nomogram showed good agreement between the nomogram prediction and actual ALNM diagnosis (P > 0.05). Decision curve analysis (DCA) revealed the net benefit of the nomogram.

Conclusions: This study developed a nomogram based on three daily available clinical parameters, with good accuracy and clinical utility, which may help the radiologist in decision-making for ultrasound-guided fine needle aspiration cytology/biopsy (US-FNAC/B) according to the nomogram score.

Keywords: axillary lymph node metastasis; breast cancer; lymphovascular invasion; nomogram; ultrasound features.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Nomogram for the prediction of ALNM in patients with breast cancer.
Figure 2
Figure 2
The calibration curves of the nomogram for the probability of ALNM.
Figure 3
Figure 3
Results of decision curve analysis. Model A = combined model, model B = image-only model. Net benefit in relation to threshold probability for ALNM.

Similar articles

Cited by

References

    1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2018. CA Cancer J Clin (2018) 68(1):7–30. doi: 10.3322/caac.21442 - DOI - PubMed
    1. Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol (2017) 35(5):561–4. doi: 10.1200/JCO.2016.71.0947 - DOI - PubMed
    1. Boughey JC, Moriarty JP, Degnim AC, Gregg MS, Egginton JS, Long KH. Cost Modeling of Preoperative Axillary Ultrasound and Fine-Needle Aspiration to Guide Surgery for Invasive Breast Cancer. Ann Surg Oncol (2010) 17(4):953–8. doi: 10.1245/s10434-010-0919-1 - DOI - PMC - PubMed
    1. Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, et al. . Morbidity Comparison of Sentinel Lymph Node Biopsy Versus Conventional Axillary Lymph Node Dissection for Breast Cancer Patients: Results of the Sentinella-GIVOM Italian Randomised Clinical Trial. Eur J Surg Oncol (2008) 34(5):508–13. doi: 10.1016/j.ejso.2007.05.017 - DOI - PubMed
    1. Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, et al. . Incorporation of Sentinel Lymph Node Metastasis Size Into a Nomogram Predicting Nonsentinel Lymph Node Involvement in Breast Cancer Patients With a Positive Sentinel Lymph Node. Ann Surg (2012) 255(1):109–15. doi: 10.1097/SLA.0b013e318238f461 - DOI - PMC - PubMed

LinkOut - more resources